Type your tag names separated by a space and hit enter

No mortality benefit with high-flow nasal oxygen in immunocompromised patients with acute hypoxemic respiratory failure

No mortality benefit with high-flow nasal oxygen in immunocompromised patients with acute hypoxemic respiratory failure is a topic covered in the EE+ POEM Archive.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

Slawson, David C., et al., editors. "No Mortality Benefit With High-flow Nasal Oxygen in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314701/all/No_mortality_benefit_with_high_flow_nasal_oxygen_in_immunocompromised_patients_with_acute_hypoxemic_respiratory_failure.
No mortality benefit with high-flow nasal oxygen in immunocompromised patients with acute hypoxemic respiratory failure. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314701/all/No_mortality_benefit_with_high_flow_nasal_oxygen_in_immunocompromised_patients_with_acute_hypoxemic_respiratory_failure. Accessed March 21, 2019.
No mortality benefit with high-flow nasal oxygen in immunocompromised patients with acute hypoxemic respiratory failure. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314701/all/No_mortality_benefit_with_high_flow_nasal_oxygen_in_immunocompromised_patients_with_acute_hypoxemic_respiratory_failure
No Mortality Benefit With High-flow Nasal Oxygen in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314701/all/No_mortality_benefit_with_high_flow_nasal_oxygen_in_immunocompromised_patients_with_acute_hypoxemic_respiratory_failure.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - No mortality benefit with high-flow nasal oxygen in immunocompromised patients with acute hypoxemic respiratory failure ID - 1314701 ED - Slawson,David C, ED - Shaughnessy,Allen F, ED - Ebell,Mark H, ED - Barry,Henry, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314701/all/No_mortality_benefit_with_high_flow_nasal_oxygen_in_immunocompromised_patients_with_acute_hypoxemic_respiratory_failure PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -